Trichothiodystrophy group A (TTD-A) patients carry a mutation in the transcription factor II H (TFIIH) subunit TTDA. Using a novel in vivo tripartite split-GFP system, we show that TTDA interacts with the TFIIH subunit p52 and the p52-TTDA-GFP product is incorporated into TFIIH. p52-TTDA-GFP is able to bind DNA and is recruited to UV-damaged DNA. Furthermore, we show that two patient-mutated TTDA proteins can interact with p52, are able to bind to the DNA and can localize to damaged DNA. Our findings give new insights into the behavior of TTDA within the context of a living cell and thereby shed light on the complex phenotype of TTD-A patients.
Introduction
Nucleotide excision repair (NER) safeguards the stability of the genome by removing a broad range of helix-distorting lesions, including UV-induced lesions (Hoeijmakers, 2009) . One of the NER key players is transcription factor II H (TFIIH). After damage recognition, the DNA helix is opened by the TFIIH bidirectional helicase function, to allow incision of the damaged strand, gap filling and ligation (Palomera-Sanchez and Zurita, 2011) . Besides NER, TFIIH is also essential for RNA polymerase I and II transcription and cell cycle regulation (Egly and Coin, 2011) . TFIIH is composed of 10 proteins, consisting of a corecomplex (XPB, XPD, p62, p52, p44, p34 and TTDA) and a cyclin activating kinase-subcomplex (CDK7, MAT1 and cyclin H) (Giglia-Mari et al., 2004) .
Hereditary mutations in TFIIH are associated with severe features, as presented by several photo-sensitive syndromes, such as trichothiodystrophy (TTD) (Lehmann, 2003) . TTD is a rare autosomal disorder and patients suffer from premature aging, progressive mental and growth retardation, ichthyosis and brittle hair and nails (Stefanini et al., 2010) . Photosensitive TTD is an exclusive TFIIH-related syndrome and three genes have been found mutated in TTD patients: XPB (Weeda et al., 1997) , XPD (Broughton et al., 1994; Stefanini et al., 1993) and TTDA (Giglia- Mari et al., 2004) . Mutations in any of these three genes cause a decrease by up to 70% in TFIIH cellular concentration (Botta et al., 2002) .
TTDA is an 8 kDa protein that stabilizes the steady-state level of TFIIH (Giglia-Mari et al., 2004; Ranish et al., 2004; Vermeulen et al., 2000) . TTDA is essential for NER by stabilizing TFIIH on the lesions (Giglia- Mari et al., 2006) and by allowing the subsequent NER factors to localize to the damage (Coin et al., 2006; Theil et al., 2011) . TTD group A (TTD-A) patients carry a mutation in TTDA and display a relatively mild TTD phenotype (Giglia-Mari et al., 2004) . Recently, it was shown that in TTD-A cells, repair is not completely abolished, but progresses slowly (Theil et al., 2011) . This also explains the mild UV sensitivity of the patient cells (Giglia-Mari et al., 2004; Vermeulen et al., 2000) . Three mutations within the TTDA gene of non-related TTD-A patients have been detected (Giglia-Mari et al., 2004) . Siblings TTD13PV and TTD14PV carry a homozygous mutation in the start codon, converting the methionine into a threonine (M1T). This will lead to either a complete loss of protein synthesis or to the production of an N-terminal truncated polypeptide when a downstream start codon at amino acid position 16 is used. Patient TTD99RO carries a homozygous transition at amino acid 56, converting an arginine into a stop codon (R56X); this truncates the protein at the C-terminal end by 23%. Patient TTD1BR has one allele identical to that of patient TTD99RO and the other allele has a transition at amino acid 21 that converts a leucine into a proline (L21P). Intriguingly, despite the rather diverse mutations, a similar appearance of the clinical features is observed among TTD-A patients (Giglia-Mari et al., 2004) .
In vitro studies have given knowledge about the binding behavior of TTDA to the TFIIH subunit p52. For now, no mutations in p52 have been reported that are linked to human disease. However, defective p52 in Drosophila melanogaster can generate TTD and cancer-like phenotypes (Fregoso et al., 2007) . Structural studies on yeast TTDA and p52 have shown that the Cterminal of p52 anchors TTDA and forms a heterodimer (Kainov et al., 2010; Kainov et al., 2008) . Further in vitro studies showed that via this interaction with p52, TTDA is able to regulate XPB ATPase activity (Coin et al., 2006) . The interaction between TTDA and p52 was validated by in vitro pull-down experiments, but has never been demonstrated in vivo. Here, we use a novel tripartite split-GFP system to study the TTDA and p52 interaction in its most relevant environment, the living cell. This three-body split-GFP system uses two b-strands of GFP, b-strand 10 (GFP10) and b-strand 11 (GFP11) as fusion tags of the proteins of interest. A large complementary detector fragment corresponds to b-strand 1-9 (GFP1-9). When the tagged proteins interact, GFP10 and GFP11 are tethered and are then capable of self-associating with the complementary GFP1-9 fragment to reconstitute full-length GFP; the cell will exhibit a green fluorescent signal (Fig. 1A) . This system has no background fluorescence and will not spontaneously self-associate as previously found with the two body split-GFP 1-10 and GFP11 (S. Cabantous, J.D. Pédelacq, H.B. Nguyen, A. Chaudhary, K. Ganguly, F. Koraïchi, M.A. Lockard, G. Favre, T.C. Terwilliger and G.S. Waldo, unpublished observations).
Using this novel system, we show that p52 interacts with TTDA in vivo. This p52-TTDA-GFP product is incorporated in TFIIH, can bind to the DNA and is recruited to an UV damaged region. Our results also demonstrate that two of the TTDA patient-mutated forms (TTDA L21P and TTDA
R56X
) can interact with p52 and that they behave the same as wild-type TTDA. Additionally, we show that the N-terminal truncated patient mutant (TTDA
M1T
) is not able to interact with p52 but still can be part of TFIIH, although the binding capacity is diminished. Our findings give new insights into TTDA behavior in binding to and functioning with TFIIH within the context of a living cell; not only in the wild-type situation, but also in relation to TTD-A patient mutations.
Results and Discussion

TTDA interacts with p52 in vivo
To investigate how TTDA interacts with TFIIH in the most relevant biological context, the living cell, we studied the binding of TTDA and p52, previously shown in structural works (Kainov et al., 2008) , using the tripartite split-GFP system (Fig. 1A) . The GFP1-9 fragment was stably expressed in human transformed fibroblasts and we have produced expressing systems with p52 Cterminally tagged with GFP11 (p52-GFP11) and TTDA (wildtype and mutated) N-terminally tagged with GFP10 (GFP10-TTDA) (supplementary material Fig. S1 ). Previously, it was shown that tagged TTDA is biologically active (Giglia- Mari et al., 2006) . Using the tripartite split-GFP technology, we demonstrate that TTDA interacts with p52 in vivo (Fig. 1B) . Along the manuscript, this protein complex will be called p52-TTDA-GFP.
TFIIH is a nuclear protein complex, however, the order of protein assembly and the cellular compartments in which this assembly takes place are not fully known. Interestingly, the GFP fluorescence produced by p52-TTDA-GFP was not only observed in the nucleus, but also in the cytoplasm, indicating that the interaction between p52 and TTDA already starts in this cellular compartment (Fig. 1B) .
To verify if the observed GFP reconstitution was not due to a false-negative event, we first tested if deleting the TTDAinteracting domain from p52 (Kainov et al., 2008) [p52(DCterm)-GFP11] hindered its interaction with TTDA. Indeed, p52(DC-term) is not able to interact with TTDA as shown by the Interactions of TTDA within TFIIH 3279
Journal of Cell Science inability to reconstitute the GFP fluorophore (supplementary material Fig. S2A,B) . Meanwhile, co-expression of p52(DC-term)-GFP11 with GFP1-10 (a large complementary detector fragment corresponding to b-strand 1-10) did show GFP fluorescence (supplementary material Fig. S2C,D) , indicating that p52(DCterm)-GFP11 is properly expressed. Furthermore, we measured the possible interaction between both TTDA and p52 with XPG. XPG is an endonuclease that closely functions together with TFIIH during NER and binds to TFIIH via the XPD subunit (Ito et al., 2007) . No interaction of XPG with TTDA or p52 has been described in the literature. Indeed, when we expressed both plasmids (XPG-GFP10 with p52-GFP11 or XPG-GFP10 with GFP11-TTDA) in the GFP1-9 cell line, we did not observe reconstitution of the GFP fluorophore (supplementary material Fig. S2E,F) .
Mutated TTDA can interact with p52
To investigate whether mutant TTDA could interact with p52, we co-expressed p52-GFP11 with the GFP10-TTDA patient mutant constructs (supplementary material Fig. S1 ) and verified the reconstitution of the GFP fluorophore. In vitro studies showed that the solubility of the TTDA mutants L21P and R56X was drastically affected when purified. Analysis of the crystallographic structure suggested that the L21P mutation may disrupt the conformation of TTDA which could result in protein unfolding (Hashimoto and Egly, 2009 ). We observed GFP fluorescence in the nucleus and the cytoplasm for both TTDA mutants, just as for wildtype TTDA (Fig. 1B) . This indicates that, despite their mutations, these two forms of TTDA are able to interact with p52 in vivo.
Previously, it was shown in vitro that an N-terminally truncated TTDA protein without the first 14 amino acids (TTDADN14) is unable to interact with p52 (Zhou et al., 2007) . Indeed, we do not observe interaction between TTDA M1T (lacking the first 15 amino acids of TTDA) and p52 (Fig. 1B) . Our results confirm that the Nterminal region of TTDA is essential for interaction with p52 in vivo. Moreover, we show that the C-terminal region of TTDA [which was also suggested in structural studies to interact with p52 (Kainov et al., 2008) ], is not sufficient for TTDA binding to p52 in vivo, without the presence of the N-terminal domain.
TTDA does not dimerize in vivo
It was proposed from structural studies that TTDA has the ability to self-associate at the N-terminal region (Vitorino et al., 2007) . To investigate this dimerization in vivo, we co-expressed GFP10-TTDA and GFP11-TTDA in the GFP1-9 cells. Interestingly, we did not observe reconstitution of the GFP fluorophore, indicating that TTDA cannot form a dimer in vivo (supplementary material Fig. S3 ).
p52-TTDA-GFP is integrated in TFIIH
Under normal conditions, p52 is a stable subunit of core-TFIIH and TTDA shuttles between a free fraction (nuclear and cytoplasmic) and a fraction bound to TFIIH (Giglia- Mari et al., 2006) . In the tripartite split-GFP system, the proteins of interest are irreversibly coupled to each other via GFP. To investigate whether this irreversible coupling between p52 and TTDA hinders p52-TTDA-GFP to be integrated into core-TFIIH, we measured the mobility of p52-TTDA-GFP and compared it to the core-TFIIH mobility by fluorescent recovery after photobleaching (FRAP) Hoogstraten et al., 2002) . Briefly, a narrow strip spanning the nucleus was photobleached and recovery of fluorescence was measured in order to determine the mobility of the proteins. XPB is a TFIIH subunit that only resides within core-TFIIH and fluorescent tagged XPB (XPB-GFP) can therefore be used to measure its mobility (Hoogstraten et al., 2002) . Our results show that the mobility of p52-TTDA-GFP is comparable to the one of XPB-GFP measured under the same conditions (Fig. 1C) . The small difference might be accounted for by the fact that within the expressing cells also endogenous p52 and TTDA proteins are present and the p52-TTDA-GFP complex therefore has to compete for its placement within TFIIH. However, the FRAP data suggest that p52-TTDA-GFP is able to integrate into core-TFIIH (p52-TTDA-GFP-TFIIH).
We further investigated whether the p52-TTDA L21P -GFP and p52-TTDA R56X -GFP complexes were able to integrate TFIIH by comparing their mobility with the one measured for the p52-TTDA WT -GFP. Fig. 1D shows that all complexes have the same mobility, indicating that also these mutant complexes are integrated into TFIIH.
p52-TTDA-GFP binds to DNA TTDA has been found to be a repair-specific TFIIH subunit in vitro and TTDA shuttling in and out of TFIIH might influence TFIIH activity in NER (Coin et al., 2006) . Since in the tripartite split-GFP system TTDA and p52 are irreversibly coupled, we verified whether the p52-TTDA-GFP-TFIIH complex is able to bind to DNA during transcription and repair. We measured the mobility of p52-TTDA-GFP-TFIIH after treatment with the transcription inhibitor DRB (5,6-dichloro-1b-D-ribofuranosyl benzimidazole) or global UV-C irradiation. Transcription inhibition increases the mobility of TFIIH by releasing the complex from the chromatin while UV treatment triggers NER in which TFIIH is bound to the DNA more tightly (Giglia- Mari et al., 2006) . We confirmed this in our experimental setting by measuring the mobility of XPB-GFP after UV or DRB treatment. Indeed, we observed a decreased mobile XPB fraction after UV irradiation and a higher mobility after DRB treatment. Furthermore, cells expressing XRCC4-GFP (non-homologous end joining repair factor), do not show a response to UV and DRB treatment (supplementary material Fig. S4 ), indicating the specificity of the FRAP experiments. Our results show that p52-TTDA-GFP-TFIIH has an increased mobility after transcription inhibition, indicating that under normal conditions, this version of TFIIH can bind to DNA on promoters. Furthermore, its mobility is reduced after UV exposure ( Fig. 2A) , meaning that the complex is most likely recruited to the damaged DNA in order to function in DNA repair.
Next, we tested whether p52-TTDA-GFP-TFIIH was able to localize on damaged DNA. We have locally irradiated a small region of the nucleus using a multiphoton laser and a clear fluorescent spot appeared at the laser targeted area, indicating that p52-TTDA-GFP-TFIIH is able to accumulate on damaged DNA (Fig. 2D) . Our results suggest that TFIIH can bind to the DNA during transcription and repair even when TTDA is not able to shuttle in and out of the complex.
Furthermore, binding of p52-TTDA-GFP-TFIIH to the DNA and recruitment to damaged DNA is not only observed for p52-TTDA WT -GFP, but also for the mutants p52-TTDA
L21P
-GFP and p52-TTDA R56X -GFP (Fig. 2B-D) .
TTDA M1T interacts with TFIIH independently of p52
We showed that TTDA M1T is not able to interact with p52 (Fig. 1B) making it impossible to study the behavior of this mutant with the tripartite split-GFP system. In order to examine if, despite the mutation, TTDA M1T is still incorporated into TFIIH and is recruited to the damaged DNA, we produced TTDA M1T -GFP-expressing cells. TTDA
M1T
-GFP fluorescence is observed in both the nucleus and the cytoplasm (Fig. 3A) just as TTDA WT -GFP, which is part of functional core-TFIIH (Giglia- Mari et al., 2006) . We induced local DNA damage with a multiphoton laser , but no accumulation of TTDA M1T -GFP at the damaged region was observed (Fig. 3B) . Absence of accumulation on damaged DNA suggests that TTDA M1T is not able to bind to TFIIH or that detection is below threshold. To discriminate between these two possibilities, we compared the mobility of TTDA WT -GFP and TTDA
-GFP by FRAP after bleaching the cytoplasm (FRAP_abc) (Giglia- Mari et al., 2006) . Our results show that TTDA M1T is slightly more mobile than TTDA WT (Fig. 3C ) but certainly less mobile than an unbound TTDA protein . Due to fast exchange of TTDA between the nucleus and cytoplasm the FRAP curves decline quickly over time and the decline is quicker in the TTDA M1T compared to TTDA WT (Fig. 3C , zoom 12-16 seconds). This faster exchange is also observed by measuring the fluorescence in the cytoplasm after bleaching the cytoplasm just before and directly after the FRAP experiment (on average 30 seconds difference). Both proteins (WT and mutant) quickly shuttle into the cytoplasm, however this shuttling (measured by an increase of fluorescence in the cytoplasm) is significantly higher for TTDA M1T (Fig. 3D) . Altogether, our results indicate that without its N-terminal region, TTDA cannot bind to p52 (tripartite split-GFP experiments), but this mutant is still able to interact with TFIIH, however not as tightly as TTDA WT (FRAP_abc data). Indeed, in vitro studies suggested that TTDA could interact with the core-TFIIH subunit XPD (Coin et al., 2006) . This interaction is apparently not stable or strong enough to see TTDA
-GFP accumulation on locally damaged DNA, but is sufficient to reduce the mobility of this mutant compared to unbound TTDA.
Concluding remarks
With the use of the tripartite-split GFP system, we show that p52 and TTDA interact within the living cell. Interestingly, this interaction is observed not just between p52 and wild-type TTDA, but also between p52 and two forms of patient-mutated TTDA: TTDA L21P and TTDA
R56X
. The p52-TTDA-GFP complex (WT and mutant) can be integrated into TFIIH, is recruited to the chromatin during transcription and accumulates on damaged DNA.
In contrast, the N-terminal truncated form (M1T) totally lacks the ability to bind p52. Despite the difference in p52 binding capacity, all patients with TTD-A have the same reduced TFIIH steady-state level of ,30% (Giglia- Mari et al., 2004; Vermeulen et al., 2000) . This means that, even though TTDA L21P and TTDA R56X retain the ability to bind p52, this is not enough to further stabilize TFIIH levels. However, despite a similar TFIIH steady state level, patient cells with TTDA M1T are slightly more sensitive to UV exposure and have less overall NER activity (Giglia- Mari et al., 2004) . We suggest that the binding of TTDA L21P and TTDA R56X to p52 still enables p52 to stimulate the ATPase-activity of XPB which is necessary for proper NER . We propose a model for TTDA interactions with TFIIH in Fig. 4 . Because the three patient mutant TTDA proteins, still interact in vivo with TFIIH (via p52 or independently of p52), we can hypothesize that these proteins keep some functionality and that they cannot be considered as null mutants.
Altogether, our observations give a further insight into the behavior of TFIIH in TTD-A patients and thereby help with the understanding of the molecular mechanisms behind the pathophysiology of this severe disease.
Materials and Methods
Cell culture and treatment SV40-immortalized human fibroblasts were cultured in 1:1 mixture of DMEM and Ham's F10 (Lonza) with antibiotics and 10% fetal bovine serum, at 37˚C and 5% CO 2 . HT1080 + XRCC4-GFP cells were cultured in DMEM with antibiotics and 10% fetal bovine serum, at 37˚C and 5% CO 2 .
Treatment: 6-7 hours 100 mg/mL DRB (5,6-dichloro-1b-D-ribofuranosyl benzimidazole) or 16 J/m 2 UV-C irradiation and imaging after 30-90 min.
Plasmids GFP1-9 was cloned into pEGFP-N3 between NheI and NotI sites. p52 and were cloned into pcDNA derived plasmids containing the GFP10 or GFP11 sequences. 
Transfection and electroporation
The MRC5-SV cells were transfected with the GFP1-9 and TTDA-GFP (WT or M1T) plasmids using JetPEI transfection reagent (Polyplus transfection) and selected with geneticin (Gibco) to obtain stable cell lines. MRC5-SV + GFP1-9 cells were co-electroporated with the GFP10 and GFP11 plasmids and left to incubate for 24-48 hours before imaging. Electroporation was performed with 4 mm cuvettes in a Gene Pulser Xcell electroporator (Bio-Rad) with a voltage of 250 V and capacity of 950 mF.
Confocal imaging
Imaging experiments were performed on a LSM 710 NLO confocal laser scanning microscope (Zeiss), using a 406/1.3 objective and under a controlled environment (37˚C, 5% CO2). Images were analyzed with ImageJ software.
FRAP
A narrow strip spanning the nucleus of a fluorescent living cell was monitored every 20 or 200 msec at 1% laser intensity (30 mW argon laser, current set at 6.5 A, 488 nm line) and photobleached at maximum laser intensity. Fluorescence recovery was monitored up to 16 seconds. For FRAP_abc, mobility measurements were obtained after bleach pulses (100% laser intensity) were applied to the cytoplasm for ,1 minute (Giglia- Mari et al., 2006; Hoogstraten et al., 2002) .
For the analysis ZEN software (Zeiss) was used. All FRAP data were normalized to average pre-bleached fluorescence after background signal removal. FRAP curves are an average of ten measured cells and error bars represent the s.e.m.
Local damage
DNA damage was induced with a tunable near-infrared pulsed laser (Cameleon Vision II, Coherent Inc., USA). A small circular area (4 mm) was targeted for 34 milliseconds (single scan iteration at 800 nm, 60% power output). The cell was imaged ,60 seconds after damage induction .
Statistics
We determined P-values by a 2-tailed Student's t-test, assuming equal variance: **P,0.01. We considered differences between groups significant at P,0.05.
